USPTO serial 97049516
ECLIPSE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 23, 2025
- Examiner
- JANSON, ANDREW KYLE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ECLIPSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kelly P. McCarthy
Kelly P. McCarthy SIDEMAN & BANCROFT LLPONE EMBARCADERO CENTER #2200SAN FRANCISCO, CA 94111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for use in planning, managing and delivering interventional oncology treatment; Downloadable software for medical image viewing, medical image processing, treatment planning and medical data analytics for operating oncology treatment devices; Downloadable computer software for use in forming medical diagnoses of oncology patients, developing oncology treatment plans, monitoring, delivering, controlling and simulating patient oncology treatment, managing and transmitting oncology patient data, information and radiographic images in relation to oncology treatment and adaptive oncology treatment, x-ray imaging for oncology treatment and adaptive oncology treatment, and controlling oncology treatment devices; Downloadable computer software for collecting, accessing, managing, maintaining, analyzing, displaying and sharing oncology patient data, oncology patient treatment information, oncology patient reported outcomes and medical imaging data in relation to oncology treatment devices; Downloadable computer software for enabling communication and collaboration among health care providers, specialists, physicians and patients, and to enable and manage medical and physician referrals in order to facilitate oncology treatment plans and adaptive oncology treatment plans; Downloadable computer software for treatment planning, namely, planning of radiation treatments; Downloadable computer software for managing adaptive radiotherapy, for medical treatment planning, and patient monitoring; Downloadable computer software for evaluating results of oncology treatment plans and adaptive oncology treatment plans; Downloadable computer software for adapting oncology treatment plans; Downloadable computer software for managing oncology patient and oncology treatment information; Downloadable computer software for operating medical imaging apparatus; Downloadable computer software for use in managing and controlling apparatus for delivering radiotherapy treatment and patient monitoring; Downloadable computer software for the creation and transmission of images and data relating to radiotherapy treatment; Downloadable software for the capture, storage, logging and evaluation of radiation data | ACTIVE | Apr 2, 2001 |
| 042 | Providing online non-downloadable software for collecting, accessing, managing, maintaining, analyzing, displaying, sharing and adapting oncology information, oncology patient data, and oncology treatment plans and adaptive oncology treatment plans; Providing online non-downloadable software for use in formulating medical diagnoses of oncology patients and developing, adapting and facilitating medical oncology treatment plans and adaptive oncology treatment plans; Providing online non-downloadable software for management and analysis of adaptive oncology treatment and oncology patient care data; Providing online non-downloadable software for operating oncology treatment devices and for creating and facilitating adaptive oncology treatment plans; Providing technical support services, namely, troubleshooting of computer hardware and software problems and providing solutions to computer software problems in the nature of computer software repair and maintenance for operating oncology treatment devices; Providing online non-downloadable software for use in planning, managing and delivering interventional oncology treatment; Providing online non-downloadable software for oncology treatment image viewing, oncology treatment image processing, and oncology treatment planning; Providing online non-downloadable software for enabling communication and collaboration among health care providers, specialists, physicians and patients, and to enable and manage medical and physician referrals in order to facilitate oncology treatment plans and adaptive oncology treatment plans; Providing online non-downloadable software for treatment planning, namely, planning of radiation treatments; Providing online non-downloadable software for managing adaptive radiotherapy, for medical treatment planning, and patient monitoring; Providing online non-downloadable computer software for evaluating results of oncology treatment plans and adaptive oncology treatment plans; Providing online non-downloadable software for adapting oncology treatment plans; Providing online non-downloadable software for managing oncology patient and oncology treatment information; Providing online non-downloadable software for operating medical imaging apparatus; Providing online non-downloadable software for use in managing and controlling apparatus for delivering radiotherapy treatment and patient monitoring; Providing online non-downloadable software for the creation or transmission of images or data relating to radiotherapy treatment; Providing online non-downloadable software for the capture, storage, logging and evaluation of radiation data | ACTIVE | Apr 2, 2001 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Varian Medical Systems, Inc.
- Other trademarks owned by Varian Medical Systems, Inc.
- Other trademarks owned by Varian Medical Systems, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named ECLIPSE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 23, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 23, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 3, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Sep 2, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Aug 5, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Aug 4, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 10, 2025 | IUAF | USE AMENDMENT FILED | — |
| Apr 10, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 3, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 21, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 20, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 20, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 1, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 1, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 1, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 1, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 9, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 14, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 14, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 25, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 6, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 25, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 24, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 24, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 13, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 13, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 13, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 13, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 21, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Dec 21, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Dec 21, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 28, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 28, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 28, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 31, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 31, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 31, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 23, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 27, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 1, 2021 | NWAP | NEW APPLICATION ENTERED | — |